rdf:type |
|
lifeskim:mentions |
umls-concept:C0004613,
umls-concept:C0030705,
umls-concept:C0033119,
umls-concept:C0034117,
umls-concept:C0037199,
umls-concept:C0054066,
umls-concept:C0205409,
umls-concept:C0293352,
umls-concept:C0370003,
umls-concept:C0441655,
umls-concept:C1510824,
umls-concept:C1533691
|
pubmed:issue |
3
|
pubmed:dateCreated |
1999-6-22
|
pubmed:abstractText |
By an agar dilution method, the antimicrobial susceptibilities of antral sinus puncture isolates were studied. Pneumococci were generally susceptible to amoxicillin, azithromycin, and clarithromycin, but 17% of pneumococcal isolates were resistant to cefuroxime. Haemophilus influenzae isolates were resistant to amoxicillin and clarithromycin. beta-Lactamase production occurred in 69% of Prevotella species. One-third of Peptostreptococcus magnus isolates were resistant to azithromycin and clarithromycin. Cefuroxime had limited activity against Prevotella species and P. magnus. Levofloxacin was active against most isolates except peptostreptococci. Amoxicillin-clavulanate was active against all isolates, with the MIC at which 90% of the isolates were inhibited being < or = 1 microgram/ml.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0066-4804
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
705-7
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:10049296-Adult,
pubmed-meshheading:10049296-Amoxicillin-Potassium Clavulanate Combination,
pubmed-meshheading:10049296-Bacteria, Aerobic,
pubmed-meshheading:10049296-Bacteria, Anaerobic,
pubmed-meshheading:10049296-Colony Count, Microbial,
pubmed-meshheading:10049296-Drug Therapy, Combination,
pubmed-meshheading:10049296-Humans,
pubmed-meshheading:10049296-Sinusitis
|
pubmed:year |
1999
|
pubmed:articleTitle |
Comparative in vitro activities of amoxicillin-clavulanate against aerobic and anaerobic bacteria isolated from antral puncture specimens from patients with sinusitis.
|
pubmed:affiliation |
R. M. Alden Research Laboratory, Santa Monica-UCLA Medical Center, Santa Monica, California 90404, USA. EJCGMD@aol.com
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|